IRAK4-IN-6 T11674
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
IRAK4-IN-6 ,targetes MyD88 L265P mutant diffuse large B cell lymphoma. is an orally efficacious and selective IRAK4 inhibitor with an IC50 of 4 nM.
CAS nr:
T11674
Purity:
98%
Molecular Weight:
504,59
SMILES:
O=C(N1CCN([C@@H]2CC[C@@H](NC3=C4C(C=CC(CC#N)=N4)=NC(NC5=CN(C)N=C5)=N3)CC2)CC1)OC
Formula:
C25H32N10O2
Pathway:
Others
Target:
Others
